NCT02670980View on ClinicalTrials.gov

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Retinitis PigmentosaCone Rod DystrophyChoroideremia
Interventions
DEVICE

Intelligent Retinal Implant System

Trial Locations (9)

8036

Medical University of Graz, Graz

20246

Klinik und Poliklinik für Augenheilkunde Hamburg -Eppendorf, Hamburg

30029

CHU Nimes, Service Ophtalmologie (France)/ Hopital Gui de Chauliac, CHU Montpelier, (France), Nîmes

44000

Clinique Ophtalmologique du CHU de Nantes, Nantes

53127

Dept. of Ophthalmology, University of Bonn, Bonn

75012

Hopital des Quinze Vingts/Fondation Ophtalmologique A. De Rothschild, Paris

79106

Universitäts KlinikumKlinik für Augenheilkunde Freiburg, Freiburg im Breisgau

08035

Instituto de Microcirugia Ocular, Barcelona

Unknown

Moorfields Eye Hospital, London

All Listed Sponsors
lead

Science Corporation

INDUSTRY

NCT02670980 - Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy | Biotech Hunter | Biotech Hunter